FS KKR Capital Corp (FSK)
The company declared a quarterly cash distribution of $0.44 per share to common stockholders, payable October 2, 2026 to shareholders of record as of September 16, 2026.
View raw filing on EDGAR →Filings Radar
SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Howmet Aerospace Inc. (HWM)
Howmet Aerospace issued a press release on August 6, 2026 announcing its second quarter 2026 financial results, including revenue of $2.547 billion (up 24% YoY), GAAP EPS of $1.33 (up 33% YoY), and adjusted EPS of $1.33 (up 46% YoY). The press release is attached as Exhibit 99.1 and constitutes a standard earnings disclosure under Item 2.02, with material financial metrics exceeding guidance and full-year guidance increased.
View raw filing on EDGAR →IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
This is a clear earnings release disclosing Q2 2026 financial results for Iovance Biotherapeutics. The filing explicitly states "issued a press release announcing its financial results for the second quarter ended June 30, 2026" under Item 2.02. The press release reports record revenue of ~$99M (up 66% YoY), gross margin of 56%, and includes business achievements and corporate updates. This is a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →Resolute Holdings Management, Inc. (RHLD)
This is a clear earnings release disclosing Resolute Holdings' financial results for Q2 2026 and the six-month period ended June 30, 2026. The press release reports quarterly EPS of $(1.53) versus $(0.07) in the prior year, Non-GAAP Fee-Related Earnings per share of $0.69 versus $0.08, and includes detailed consolidated financial statements (balance sheet, income statement, and cash flows). The filing explicitly states the press release is attached as Exhibit 99.1 and Item 2.02 is the standard Item for earnings disclosures.
View raw filing on EDGAR →IRONWOOD PHARMACEUTICALS INC (IRWD)
Ironwood Pharmaceuticals disclosed Q2 2026 financial results with total revenue of $113 million, GAAP net income of $51 million, and adjusted EBITDA of $83 million, along with raised full-year 2026 guidance for U.S. LINZESS net sales ($1.15–$1.20 billion), total revenue ($460–$485 million), and adjusted EBITDA (>$310 million).
View raw filing on EDGAR →Aclaris Therapeutics, Inc. (ACRS)
This is a clear earnings release disclosing Aclaris Therapeutics' financial results for Q2 2026 and the six months ended June 30, 2026. The filing includes condensed consolidated statements of operations showing net loss of $21.5 million for Q2 2026 and $41.3 million for the six-month period, along with balance sheet and cash flow data. The press release (Exhibit 99.1) announces these quarterly and year-to-date financial results, which is the hallmark of an earnings_release event under Item 2.02.
View raw filing on EDGAR →COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI)
This is a clear earnings release disclosing Cogent Communications' Q2 2026 financial results. The Item 2.02 section explicitly states that "Cogent Communications Holdings, Inc. issued a press release summarizing its financial results for the second quarter of 2026" and the press release (Exhibit 99.1) provides comprehensive quarterly financial data including service revenue ($235.6 million), EBITDA, gross profit, earnings per share ($1.39), and detailed operational metrics. This is the standard form of quarterly earnings disclosure.
View raw filing on EDGAR →RE/MAX Holdings, Inc. (RMAX)
This disclosure presents the board composition of the "Real REMAX Group" expected to serve after closing of a transaction, listing ten directors with their backgrounds and committee assignments. The filing references a "joint proxy statement/prospectus" and "management information circular," indicating this is part of a merger or acquisition transaction. While the Item 8.01 classification and governance focus suggest this is a governance event related to board composition post-transaction, the specific nature of the transaction (M&A activity) is not detailed in this excerpt. The board composition disclosure itself is governance-related but does not fit the specific categories of exec_appointment, exec_departure, or exec_compensation; it is a broader governance disclosure tied to a material transaction.
View raw filing on EDGAR →Sunstone Hotel Investors, Inc. (SHO-PI)
This is a clear earnings release for Q2 2026 ended June 30, 2026. The press release discloses quarterly financial results including net income ($26.0 million), diluted EPS ($0.14), RevPAR metrics, Adjusted EBITDAre ($76.7 million), and Adjusted FFO per share ($0.32), along with updated full-year 2026 guidance. The filing is structured as Item 2.02 with the press release attached as Exhibit 99.1, which is the standard format for earnings disclosures.
View raw filing on EDGAR →Payoneer Global Inc. (PAYO)
This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) filed under Item 2.02 Results of Operations and Financial Condition. The press release discloses key financial metrics including revenue of $274.3M (5% YoY growth), volume of $23.7B (15% YoY growth), and operational highlights. While the filing also mentions the pending Nuvei acquisition, the primary disclosure under Item 2.02 is the quarterly financial results announcement, which is material to investors assessing the company's operational performance.
View raw filing on EDGAR →Real Brokerage Inc (REAX)
This 6-K discloses the composition and governance structure of the Real REMAX Group Board expected to take office upon closing of the merger between Real Brokerage Inc. and RE/MAX Holdings, Inc. (announced April 26, 2026, expected to close in H2 2026). The filing details ten directors, their backgrounds, committee assignments, and committee charters. While the merger itself (ma_activity) is the underlying transaction, this exhibit focuses on post-closing governance and board composition—a material governance event for a combined entity that will trade on Nasdaq under ticker REAX. The disclosure is governance-related but does not fit a specific named category (not an appointment or departure of a single executive, nor a compensation arrangement), making governance_other the appropriate classification.
View raw filing on EDGAR →DAQO NEW ENERGY CORP. (DQ)
This is an announcement of an upcoming earnings release for Q2 2026 (unaudited financial results for the quarter ended June 30, 2026) scheduled for August 20, 2026. While the actual results are not disclosed in this exhibit, the announcement itself constitutes a material disclosure of the timing and logistics for the earnings announcement, which is a standard material event for public companies. The exhibit includes conference call details and webcast information for investors to access the results.
View raw filing on EDGAR →Edgewise Therapeutics, Inc. (EWTX)
Item 2.02 discloses Edgewise's second quarter 2026 financial results via press release, including R&D expenses ($47.5M), G&A expenses ($14.4M), and net loss ($57.3M or $0.53 per share). The filing explicitly states "Edgewise Therapeutics, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026," with the full press release attached as Exhibit 99.1. This is a standard quarterly earnings disclosure material to investors assessing the company's financial condition and operational performance.
View raw filing on EDGAR →Theriva Biologics, Inc. (TOVX)
Theriva Biologics announced dosing of the first patient in the VIRAGE2 Phase 2a trial evaluating more frequent dosing of VCN-01 in metastatic pancreatic cancer, representing a material clinical development milestone for the company's lead candidate.
View raw filing on EDGAR →SUNCOR ENERGY INC (SU)
The exhibit announces Peter Zebedee's appointment as President and Chief Financial Officer effective September 14, 2026, and his planned appointment as President and Chief Executive Officer in April 2027, following a rigorous Board succession process. While Rich Kruger's transition to Executive Vice Chair also occurs, the principal disclosed action is Peter's appointment to these senior executive roles. The announcement also includes appointments of Adam Albeldawi as Executive Vice President Upstream and Shelley Powell as Executive Vice President Development and Projects, all material leadership changes at a major energy company.
View raw filing on EDGAR →Ocugen, Inc. (OCGN)
Ocugen issued a press release on August 6, 2026, announcing second quarter 2026 financial results, including cash position ($100.4M as of June 30, 2026), operating expenses ($17.9M for Q2 2026), and net loss per share ($0.07). The filing explicitly states the Company "reported second quarter 2026 financial results" and includes condensed consolidated balance sheets and statements of operations. This is a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →CION Investment Corp (CICB)
CION Investment Corporation reported second quarter 2026 financial results, including net investment income of $0.29 per share, earnings per share of $0.62, and net asset value per share of $13.57, along with detailed portfolio and operational metrics.
View raw filing on EDGAR →AXCELIS TECHNOLOGIES INC (ACLS)
The 8-K discloses Axcelis Technologies' financial results for Q2 2026 (quarter ended June 30, 2026) via a press release attached as Exhibit 99.1. Item 2.02 explicitly states the company "issued a press release regarding its financial results for its quarter ended June 30, 2026," with revenue of $215.2 million, GAAP diluted EPS of $0.75, and non-GAAP diluted EPS of $1.06. This is a standard quarterly earnings release material to investors.
View raw filing on EDGAR →Scholar Rock Holding Corp (SRRK)
Scholar Rock filed a prospectus supplement on August 6, 2026 to offer and sell up to $200 million in additional shares of common stock through an at-the-market (ATM) offering program. This is a registered equity issuance that will dilute existing shareholders and represents a material capital-raising event. The company has already raised approximately $257.7 million under the ATM Program, and this new prospectus supplement authorizes an additional $200 million in offerings.
View raw filing on EDGAR →The9 LTD (NCTY)
This press release announces The9's expansion of brand partnerships for its the9bit platform across Southeast Asia, with 41 signed agreements and 127 in the pipeline. The disclosure highlights a strategic business development initiative involving partnerships with major regional brands (Tealive, Highlands Coffee, etc.), paid marketing-services revenue streams, and platform engagement metrics (120,000 daily active users). While this is clearly an operational/strategic business event rather than a discrete M&A transaction, earnings release, or other named event type, the scale of the partnership network, revenue generation from paid engagements, and token appreciation (35% rise in $9BIT) suggest material significance to investors assessing the company's growth trajectory and business diversification.
View raw filing on EDGAR →AMERICAN HONDA RECEIVABLES LLC
American Honda Receivables LLC and American Honda Finance Corporation entered into an Underwriting Agreement on August 4, 2026 for the issuance of approximately $2.1 billion in asset-backed notes across five classes with varying rates, pursuant to an Indenture with Citibank as indenture trustee. The securitization structure involves transfer of retail installment sale contracts (receivables) from AHFC to AHR LLC and then to the Issuer in exchange for the issuance of Notes.
View raw filing on EDGAR →AMERICAN HONDA RECEIVABLES LLC
The registrant filed a prospectus describing the issuance of approximately $2.1 billion in aggregate principal amount of asset-backed notes across five classes (Class A-1 through Class A-4) by Honda Auto Receivables 2026-3 Owner Trust. This constitutes creation of a new direct financial obligation through debt issuance, a material capital-raising event typical of securitization transactions. The specific principal amounts and note classes indicate a structured debt offering.
View raw filing on EDGAR →ENI SPA (EIPAF)
This is Eni's Interim Consolidated Report as of June 30, 2026, covering the first half of 2026. The document explicitly states "Interim Consolidated Report as of June 30, 2026" in the table of contents and contains condensed consolidated interim financial statements with notes, management certification, and an independent auditors' report. This is a periodic interim financial report (the foreign-issuer equivalent of a 10-Q), not a discrete event or earnings press release.
View raw filing on EDGAR →INTERNATIONAL BANCSHARES CORP (IBOC)
International Bancshares Corporation issued a news release on August 6, 2026, announcing net income for the three and six months ended June 30, 2026. The release discloses quarterly and year-to-date financial results including net income ($198.0 million for six months, $95.8 million for Q2), diluted earnings per share ($3.18 and $1.54 respectively), and balance sheet metrics (total assets, loans, deposits). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →Trinseo PLC (TSEOF)
This is a clear earnings release disclosing Trinseo's second quarter and six-month financial results for the period ended June 30, 2026. The press release (Exhibit 99.1) presents net sales of $845 million for Q2 2026, net loss of $120 million, diluted EPS of $(3.27), and detailed segment performance. The filing explicitly states the Company "issued a press release announcing its financial results for the second quarter and year ended June 30, 2026," which is the hallmark of an earnings_release event under Item 2.02.
View raw filing on EDGAR →AMPHENOL CORP /DE/ (APH)
The filing discloses two capital-related events: (1) approval of a two-for-one stock split in the form of a stock dividend to be distributed September 2, 2026, and (2) approval of a third-quarter 2026 cash dividend of $0.25 per share (pre-split) payable October 14, 2026. While a stock split is technically a capital structure adjustment, it is presented here as a "stock dividend" distribution to shareholders. The filing emphasizes both the stock split/dividend and the cash dividend announcement, making dividend_distribution the most appropriate classification as it encompasses both distributions to shareholders. The stock split is material to investors as it affects share count and per-share metrics.
View raw filing on EDGAR →Lulu's Fashion Lounge Holdings, Inc. (LVLU)
The Company discloses regaining compliance with Nasdaq continued listing requirements after previously failing to meet the minimum stockholders' equity standard of $2.5 million (May 21, 2026). While the disclosure is positive (resolution of delisting risk), the core event is the Company's prior non-compliance with listing standards and the subsequent remediation. This directly addresses delisting risk under Item 8.01, as the Company had been at material risk of delisting and has now satisfied the alternative MVLS Standard of $35 million in market value of listed securities.
View raw filing on EDGAR →AerSale Corp (ASLE)
AerSale issued a press release on August 6, 2026 announcing its financial results for the fiscal quarter ended June 30, 2026, disclosing revenue of $70.9 million (down 33.9% YoY), a net loss of $5.6 million (versus net income of $8.6 million in Q2 2025), and adjusted EBITDA of $2.2 million (down 87.9% YoY). The filing explicitly states the press release is furnished as Exhibit 99.1 and includes detailed financial statements and segment performance data, which is the standard format for quarterly earnings releases under Item 2.02.
View raw filing on EDGAR →Rigetti Computing, Inc. (RGTIW)
This is a straightforward earnings release disclosing Rigetti's financial results for Q2 2026 (three and six months ended June 30, 2026). The press release, furnished as Exhibit 99.1, reports total revenues of $5.1 million, operating loss of $28.1 million, GAAP net loss of $52.6 million, and cash position of $541.3 million as of June 30, 2026. Item 2.02 explicitly covers "Results of Operations and Financial Condition," and the disclosure includes both financial highlights and business updates typical of a quarterly earnings announcement.
View raw filing on EDGAR →Texas Roadhouse, Inc. (TXRH)
Texas Roadhouse disclosed financial results for the 13 and 26 weeks ended June 30, 2026, including comparable restaurant sales growth of 6.2% and 6.7% respectively, net income, diluted EPS, and 2026 guidance.
View raw filing on EDGAR →Texas Roadhouse, Inc. (TXRH)
On August 5, 2026, the Board of Directors approved a quarterly cash dividend of $0.75 per share, payable on September 29, 2026.
View raw filing on EDGAR →MetaVia Inc. (MTVA)
MetaVia issued a press release on August 6, 2026, announcing financial results for Q2 2026 ended June 30, 2026, including a net loss of $5.3 million ($0.90 per share), R&D expenses of $3.5 million, G&A expenses of $1.9 million, and a cash position of $12.6 million, along with clinical development milestones.
View raw filing on EDGAR →Westrock Coffee Co (WEST)
This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "Westrock Coffee Company (the 'Company') issued a press release announcing its financial results for the second quarter ended June 30, 2026," with the earnings press release furnished as Exhibit 99.1. The exhibit contains detailed financial statements, segment results, and forward guidance, which are hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →Astrana Health, Inc. (ASTH)
Astrana Health issued a press release on August 6, 2026 announcing financial results for Q2 2026 and the six months ended June 30, 2026, reporting revenue of $972.5 million (up 49% YoY), net income of $18.5 million (up 81% YoY), and adjusted EBITDA of $68.9 million (up 43% YoY), along with updated 2026 guidance. A conference call and earnings presentation were furnished to discuss the results.
View raw filing on EDGAR →RE/MAX Holdings, Inc. (RMAX)
RE/MAX Holdings issued a press release on August 6, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing total revenue of $68.5 million, net loss of $4.3 million, and Adjusted EBITDA of $22.9 million. This is a standard quarterly earnings release filed under Item 2.02 (Results of Operations and Financial Conditions), with the full text furnished as Exhibit 99.1.
View raw filing on EDGAR →CVRx, Inc. (CVRX)
CVRx issued a press release on August 6, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing revenue of $15.7 million (16% growth), gross margin of 87%, net loss of $14.0 million, and updated full-year 2026 guidance. The filing explicitly states the press release is attached as Exhibit 99.1 and incorporated by reference under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. This is a material disclosure affecting investor assessment of the company's financial performance and outlook.
View raw filing on EDGAR →EQUINIX INC (EQIX)
Equinix issued $3.0 billion in aggregate principal amount of senior notes across four tranches (2029, 2031, 2033, and 2036 notes) on August 6, 2026. This is a material creation of direct financial obligations disclosed under Item 8.01, representing a significant debt capital raise that would affect a reasonable investor's assessment of the company's capital structure and financial position.
View raw filing on EDGAR →INNODATA INC (INOD)
The filing discloses the appointment of Rahul Singhal as Chief Executive Officer and Principal Executive Officer effective September 30, 2026, along with his election to the Board of Directors. While the filing also mentions Jack Abuhoff's transition from CEO to Executive Chairman, the principal disclosed action centers on Singhal's appointment to the CEO role and board membership. This is a material executive succession event at a public company with strong recent financial performance (58% YoY revenue growth, record results).
View raw filing on EDGAR →Structure Therapeutics Inc. (GPCR)
Structure Therapeutics issued a press release on August 6, 2026 providing financial results for the second quarter ended June 30, 2026, including R&D expenses of $100.1 million, G&A expenses of $18.6 million, and a net loss of $106.2 million. The filing explicitly states this is a disclosure of "Results of Operations and Financial Condition" under Item 2.02, with the full press release furnished as Exhibit 99.1. This is a standard quarterly earnings release disclosing material financial results.
View raw filing on EDGAR →Senseonics Holdings, Inc. (SENS)
This is a clear earnings release for Q2 2026 financial results. The Item 2.02 disclosure announces second quarter revenue of $14.5 million (120% YoY growth), gross margin of 59%, and raises full-year 2026 revenue guidance to $62–66 million. The press release (Exhibit 99.1) contains detailed financial statements, operational highlights, and forward-looking guidance, which are hallmarks of an earnings announcement. Material to investors as it reflects strong commercial momentum and improved financial performance.
View raw filing on EDGAR →D-MARKET Electronic Services & Trading (HEPS)
This exhibit is a press release announcing Hepsiburada's unaudited financial results for Q2 2026 and H1 2026, dated August 6, 2026. It discloses key metrics including GMV, revenue, orders, EBITDA, and net loss, along with detailed financial tables and management commentary. Although the filing includes a restatement pursuant to IAS 29 (hyperinflation accounting), the primary disclosure is the quarterly earnings announcement, which is a material event affecting investor assessment of the company's financial performance and operational trends.
View raw filing on EDGAR →NextCure, Inc. (NXTC)
The Item 2.02 disclosure announces Q2 2026 financial results for the quarter ended June 30, 2026, with detailed metrics including cash position ($20.1M), R&D expenses ($7.4M), G&A expenses ($2.6M), asset impairment charges ($5.1M), and net loss ($14.9M). However, the press release is dominated by the announcement of a proposed merger with Avere Therapeutics and related restructuring activities, which materially overshadows the routine quarterly results disclosure. While this is technically an earnings release, the merger announcement (an M&A activity) is the primary material event driving the filing.
View raw filing on EDGAR →Willdan Group, Inc. (WLDN)
Willdan issued a press release on August 6, 2026 announcing financial results for the second quarter ended July 3, 2026, with contract revenue of $231.0 million (up 33.2%), net income of $24.3 million (up 57.7%), and GAAP diluted EPS of $1.58 (up 53.4%). The filing explicitly states this is Item 2.02 disclosure with the press release attached as Exhibit 99.1, which is the standard format for earnings releases. The company also raised FY2026 financial targets, indicating material performance updates.
View raw filing on EDGAR →Clean Energy Fuels Corp. (CLNE)
Clean Energy Fuels Corp. issued a press release on August 6, 2026, announcing financial results for Q2 2026 ended June 30, 2026. The disclosure includes revenue of $106.4 million, net loss of $(14.9) million, and Adjusted EBITDA of $16.0 million, along with operational metrics such as RNG gallons sold (63.2 million). This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is the designated Item for results of operations and financial condition.
View raw filing on EDGAR →ESCO TECHNOLOGIES INC (ESE)
ESCO Technologies disclosed its fiscal 2026 third quarter financial and operating results on August 6, 2026, reporting Q3 2026 sales of $339 million (14% increase), GAAP EPS from continuing operations of $1.26 (31% increase), and Adjusted EPS of $2.20 (38% increase), along with updated full-year FY 2026 guidance raising both sales and Adjusted EPS expectations.
View raw filing on EDGAR →VICI Properties L.P.
VICI Properties L.P. entered into an underwriting agreement to issue $900 million of 5.400% Senior Notes due 2031 and $850 million of 5.750% Senior Notes due 2036, with net proceeds of approximately $1,720 million intended for refinancing maturing debt and general corporate purposes. A legal opinion from Cadwalader US LLP dated August 6, 2026 confirmed the legality of the Notes.
View raw filing on EDGAR →COGNITION THERAPEUTICS INC (CGTX)
This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) issued on August 6, 2026. The press release discloses financial results including R&D expenses ($5.1M vs $11.5M YoY), G&A expenses ($2.6M vs $2.5M YoY), net loss ($3.9M or $0.04 per share vs $6.7M or $0.11 per share YoY), and balance sheet data as of June 30, 2026. The filing includes unaudited selected financial data in tabular form and is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings releases.
View raw filing on EDGAR →Cytosorbents Corp (CTSO)
The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release dated August 6, 2026 announcing CytoSorbents' financial results for the quarter ended June 30, 2026. The press release provides detailed Q2 2026 financial metrics including revenue ($9.6M), gross margin (73%), operating loss ($2.6M), net loss ($4.4M), and adjusted EBITDA loss ($1.6M), along with business highlights and regulatory updates. This is a standard quarterly earnings release disclosure.
View raw filing on EDGAR →Global Net Lease, Inc. (GNL-PD)
The 8-K discloses Global Net Lease's second quarter 2026 financial results through Item 7.01 (Regulation FD Disclosure), with a furnished earnings call transcript. The filing reports Q2 2026 revenue of $112.5 million, AFFO of $0.22 per share, and updated full-year 2026 guidance (AFFO per share raised to $0.82–$0.85 range, transaction volume guidance increased to $700–$800 million). This is a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →Clarus Corp (CLAR)
This is a clear earnings release for Q2 2026 ended June 30, 2026. The press release (Exhibit 99.1) discloses comprehensive financial results including sales of $56.2 million, net income of $4.7 million ($0.12 per diluted share), adjusted EBITDA of $7.6 million, and full-year 2026 guidance. The filing is made under Item 2.02 (Results of Operations and Financial Condition), the standard Item for earnings disclosures, and includes both GAAP and non-GAAP measures with reconciliations.
View raw filing on EDGAR →